Use of GtfB as a Diagnostic for Caries Activity

使用 GTfB 作为龋齿活动的诊断

基本信息

  • 批准号:
    7482074
  • 负责人:
  • 金额:
    $ 18.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-05-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The over-arching objective of this application is the creation of a simple, rapid, inexpensive diagnostic test that can be used during an office visit to detect caries activity before overt carious lesions are apparent so that interventions can be made before permanent damage to the dentition occurs. The specific objective of this application is the clinical validation of an immunoassay measuring GtfB as a saliva-based marker for caries activity in children from a population where Early Childhood Caries (ECC) is prevalent. This method is predicated on an intimate understanding of the pathogenesis of Dental caries. Three glycosyltransferases (GtfB, GtfC and GtfD) are secreted by S. mutans when it colonizes the tooth surface. These enzymes cleave dietary sucrose into its constituent monosaccharides, glucose which is polymerized into soluble and insoluble glucans that create the tightly adherent, bacteria-rich biofilm that characterizes caries, and fructose which is utilized as an energy source and yields enamel-dissolving acids. The central role of Gtfs in disease progression makes them plausible markers for active caries. In a recent cross-sectional clinical trial, the Bowen laboratory distinguished children with ECC from disease-free children with about 80% diagnostic accuracy by measuring the levels of GtfB in their saliva. With such a promising start, two issues become paramount: 1) whether the GtfB immunoassay will be an effective tool for identifying caries-active children prospectively; and 2) ways by which the clinical performance of the assay can be optimized while the method is made useable in an office setting. This application addresses exactly these questions. The focus of Specific Aim 1 is a 100 patient clinical trial to determine whether GtfB measurement can identify children who have the disease Dental caries before they have clinically detectable carious lesions. Clinically caries-free children 24-60 months old will be examined for white spot lesions or frank cavitation every three months for a year. Saliva samples will be taken at the same time and GtfB measured. The clinical question will be: It is not clear whether elevated salivary GtfB values predict the emergence of detectable carious lesions 3, 6 or 9 months later. Specific Aims 2 and 3 address the creation of additional anti-GtfB monoclonal antibodies and alternative immunoassay formats so we can ultimately make a saliva-based, rapid, inexpensive, instrument-free diagnostic test for incipient Dental caries. Public Health Significance: Use of GtfB as a Diagnostic for Caries Activity. Dental caries remains a major source of morbidity and expense. In the United States alone, $48 billion are spent each year repairing the consequences of this completely preventable disease. A particularly severe form, Early Childhood Caries (ECC) is common in impoverished urban and rural populations creating what the Report of the Surgeon General called a silent epidemic. Among the tools needed for reducing the burden of Dental caries is a simple, inexpensive, in-office, diagnostic test that can identify children with active caries so that interventions can be made before their teeth become irreversibly damaged. The diagnostic must be simple and rapid enough that it can be used in a pediatric or Dental office. The first goal is to validate a saliva-borne, pathogen-derived marker that is the proposed analyte in such a longitudinal test.
描述(由申请人提供):本申请的总体目标是创建一种简单、快速、廉价的诊断测试,可在就诊期间用于在明显的龋损之前检测龋齿活动,以便在牙列发生永久性损害之前进行干预。这项应用的具体目标是临床验证GTFB作为唾液标记物在早期儿童龋病(ECC)流行人群中作为儿童龋齿活动标志物的临床有效性。这种方法是建立在对龋齿发病机制的深入了解基础上的。变形链球菌在牙齿表面定植时可分泌三种糖基转移酶(GTFB、GTFc和GTFD)。这些酶将饮食中的蔗糖裂解成其组成的单糖、葡萄糖和果糖,葡萄糖被聚合成可溶和不溶的葡聚糖,后者产生紧密附着的、富含细菌的生物膜,这是龋齿的特征,果糖被用作能源,产生溶解釉质的酸。GTFS在疾病进展中的核心作用使其成为活动性龋病的可信标记物。在最近的一项横断面临床试验中,鲍文实验室通过测量唾液中的GTFB水平,以约80%的诊断准确率区分患有ECC的儿童和没有疾病的儿童。有了这样一个有希望的开端,两个问题变得至关重要:1)GTFB免疫分析是否将成为前瞻性地识别龋齿活跃儿童的有效工具;2)如何在办公室环境中使用该方法的同时,优化该分析的临床性能。这个应用程序恰恰解决了这些问题。具体目标1的重点是一项100名患者的临床试验,以确定GTFB测量是否可以在儿童出现临床可检测到的龋损之前识别出患有龋病的儿童。临床上无龋齿的24-60个月的儿童将每三个月检查一次白斑病变或坦率的空洞,为期一年。同时采集唾液样本,测定GTFB。临床问题是:尚不清楚唾液GTFB升高是否预示着3个月、6个月或9个月后出现可检测到的龋损。具体目标2和3解决了创建额外的抗GTFB单抗和替代免疫分析形式,以便我们最终能够做出一种基于唾液的、快速、廉价的、无需仪器的早期龋齿诊断测试。公共卫生意义:使用GTFB作为龋病活动的诊断指标。龋齿仍然是发病率和费用的主要来源。仅在美国,每年就花费480亿美元来修复这种完全可以预防的疾病的后果。一种特别严重的形式,早期儿童龋病(ECC)在贫困的城市和农村人口中很常见,造成了卫生局局长报告中所说的无声流行病。在减轻龋齿负担所需的工具中,有一种简单、廉价、在岗的诊断测试,可以识别患有活动性龋齿的儿童,以便在他们的牙齿受到不可逆转的损害之前进行干预。诊断必须足够简单和快速,以便可以在儿科或牙科办公室使用。第一个目标是验证一种唾液传播的、病原体衍生的标记物,它是这种纵向测试中建议的分析物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John Linforth Daiss其他文献

John Linforth Daiss的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John Linforth Daiss', 18)}}的其他基金

Core 1: Osteoimmunology Core
核心1:骨免疫学核心
  • 批准号:
    10247794
  • 财政年份:
    2017
  • 资助金额:
    $ 18.6万
  • 项目类别:
Anti-Autolysin Passive Immunity for MRSA Osteomyelitis
MRSA 骨髓炎的抗自溶素被动免疫
  • 批准号:
    7999014
  • 财政年份:
    2010
  • 资助金额:
    $ 18.6万
  • 项目类别:
Coupled Gene Delivery and Protein Transduction for the Reduction of Atheroscleros
联合基因传递和蛋白质转导可减少动脉粥样硬化
  • 批准号:
    7612615
  • 财政年份:
    2009
  • 资助金额:
    $ 18.6万
  • 项目类别:
Core 1: Osteoimmunology Core
核心1:骨免疫学核心
  • 批准号:
    9370635
  • 财政年份:
  • 资助金额:
    $ 18.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了